about
Women and HIVA randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individualsRising population cost for treating people living with HIV in the UK, 1997-2013Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection.The need for data on women living with HIV in Europe.Defining cognitive impairment in people-living-with-HIV: the POPPY study.HIV in East London: ethnicity, gender and risk. Design and methodsAntiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South AfricaData linkage reduces loss to follow-up in an observational HIV cohort study.Sexual health of ethnic minority MSM in Britain (MESH project): design and methods.Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmission.Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study.Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.HIV testing in non-traditional settings--the HINTS study: a multi-centre observational study of feasibility and acceptabilityUsing two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women.Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA studyDoes pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?The effect of tenofovir on renal function in HIV-positive pregnant women.Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in Kwazulu-Natal, South Africa.Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse.Antiretroviral therapy CNS penetration and HIV-1-associated CNS diseaseAn evaluation of the performance of OraQuick ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK.The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics.The Men's Safer Sex (MenSS) trial: protocol for a pilot randomised controlled trial of an interactive digital intervention to increase condom use in menResponse to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve womenImpact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.Antiretrovirals and the use of traditional, complementary and alternative medicine by HIV patients in Kwazulu-Natal, South Africa: a longitudinal study.Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.Defining the Content of an Online Sexual Health Intervention: The MenSS Website.Does general practice deliver safe primary care to people living with HIV? A case-notes reviewTreatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conceptionThe Men's Safer Sex project: intervention development and feasibility randomised controlled trial of an interactive digital intervention to increase condom use in men.The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy.Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.Outcome of patients with HIV-related germ cell tumours: a case-control study.A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant CharacteristicsExperience of delivering women with HIV in an inner city London hospital 1994-2004.Disease Progression in HIV-1-Infected Viremic Controllers.
P50
Q22242693-10047456-F258-4203-AC22-888691E19A00Q28543212-ECF76B96-D53F-4AD3-9C57-389E16589CECQ28743848-A18C865A-4B5E-41F9-9498-F945DFAA3C2FQ28744286-5D96CCBF-E004-48A9-90AC-4C94A751AD2AQ30392301-BF3669AF-7A90-4A98-A259-3ACF181D17F9Q30650427-599E3B9E-A876-4A82-8AD1-1FAA06B62895Q30826784-EB42AF7F-7572-408A-A739-F1E7756D8D6DQ33246294-AD7FCB34-BD3E-4E9F-8C28-24B045605935Q33537373-378FA35A-3984-48DC-B9A2-A1049181B917Q33546856-239E5E67-9A81-4CE4-9120-D0F20FCC71A6Q33632691-AD98922D-BDEF-46B9-9F6D-A1F925314D1BQ33679501-7852BCBC-CE4E-4241-A9A9-1AFFB7F4EEBEQ34257658-7FDD4CE5-32A8-45A9-9403-CD8A6AB81D2EQ34310482-15089AAF-0BE8-47CD-991B-B920188DF504Q34321493-189DC1BC-DD19-4920-B8D2-5897CB7CF56DQ34354318-8143B3FC-1A91-43A5-B5C3-9D73F33CF1E4Q34405742-31E41148-AB92-4CE4-AA5F-22D0423EDB15Q34475008-6C8D2876-F1D6-44ED-842E-D69A473EC3F6Q34475034-E6701A02-E6FB-40C5-9B65-557888B1D9EBQ34477254-DB194644-76DB-494C-9776-4A89571287B7Q34491241-C57B4B9F-B80B-41A0-B242-056C8818A2F1Q34620573-F092CF49-80D0-4F05-B9C6-4C21D341A337Q34647014-FCBD06E6-B53A-4C32-95BF-AB24153456B3Q34840517-9707459E-99A4-4B1D-ACB3-D567371EE842Q35021706-89E43FBC-A67E-4956-878F-A71ADC483277Q35107561-83D041DD-0244-421F-9935-E15283A25396Q35110099-955A50D7-2679-48D2-8DF1-3196EAEBD3C5Q35316315-1BF2C21C-860A-4663-AD71-11F4F6D1DF08Q35556648-515591F5-A745-418D-9FB2-0AB67B04A5D6Q35629349-E1C54592-36BE-4086-813A-EE612BC64C2DQ35922524-79638C18-9E32-4FBF-9F5D-898A7E3FE63CQ36092612-628E33BE-E854-4D1E-86AA-6FB93A01C1FAQ36193392-19A74BAD-8CB1-4FF6-9E7A-7A5D9CB16B27Q36223093-6D65B6FA-3DEB-4443-BC50-B5A50D892498Q36243467-9818701D-60BB-49BA-AD59-78FE11C411DFQ36389902-8B435A2D-32D8-4DA8-9ED1-1DC79D05A4AEQ36694972-A541EFD3-1A7A-4E2C-A73A-EC6CFE2FD6BEQ36874841-8B88445E-B412-49C0-9658-0EF18CA2AD3EQ36905008-EF9D4EA2-6C0B-4150-BDC7-ACC95B454EBEQ37077305-206D54FB-C722-4470-A2A6-DFD122B5D0A9
P50
description
Clinician and researcher in the field of HIV
@en
wetenschapper
@nl
name
Jane Anderson
@af
Jane Anderson
@an
Jane Anderson
@ast
Jane Anderson
@bar
Jane Anderson
@br
Jane Anderson
@ca
Jane Anderson
@co
Jane Anderson
@cs
Jane Anderson
@cy
Jane Anderson
@da
type
label
Jane Anderson
@af
Jane Anderson
@an
Jane Anderson
@ast
Jane Anderson
@bar
Jane Anderson
@br
Jane Anderson
@ca
Jane Anderson
@co
Jane Anderson
@cs
Jane Anderson
@cy
Jane Anderson
@da
prefLabel
Jane Anderson
@af
Jane Anderson
@an
Jane Anderson
@ast
Jane Anderson
@bar
Jane Anderson
@br
Jane Anderson
@ca
Jane Anderson
@co
Jane Anderson
@cs
Jane Anderson
@cy
Jane Anderson
@da
P108
P106
P1153
15729271400
P21
P31
P496
0000-0001-5294-8707
P569
2000-01-01T00:00:00Z